
Osteoarthritis
Reduced pain and disability over 26 weeks in patients treated with IA hyaluronan vs. sham
Clin Ther. 1998 May-Jun;20(3):410-23110 patients (117 knees) with knee osteoarthritis were randomized to three weekly intra-articular injections of either hyaluronan (HA) (Hylan G-F 20) or saline. The purpose of this study was to evaluate and compare outcomes of pain and loss of activity between groups. Visual analog scales were used in the evaluation of patients over 26 weeks following the first injection. Results demonstrated significantly lower pain on weight-bearing and at rest in the HA group compared to the control group over the 26 week assessment period. Additionally, loss of activity was significantly lower in the HA versus control group throughout follow-up.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.